Ponsegromab for the Treatment of Cancer Cachexia

The monoclonal antibody ponsegromab increased weight, improved appetite, and led to increased physical activity in patients with cancer cachexia who had lost weight during the previous 6 months.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology